Research
First successful human challenge model for dengue serotype 4 could speed vaccine and drug testing
The Brief
- Researchers at the University of Maryland School of Medicine and the Institute of Human Virology developed the first successful human challenge model for dengue serotype 4.
- The model is intended to speed the testing of new drugs and vaccines against dengue serotype 4.
- The source report is a short excerpt; further technical details are not available from the provided sources.
Why it matters
A working human challenge model gives researchers a controlled way to test dengue serotype 4 drugs and vaccines, which could shorten development timelines for a major mosquito-borne disease.
Who’s affected
- vaccine and antiviral researchers
- public health agencies monitoring dengue
- dengue serotype 4
- #dengue
- #human challenge model
- #vaccines
- #antivirals
- #infectious disease
Researchers at the University of Maryland School of Medicine (UMSOM) and the Institute of Human Virology (IHV) have developed the first successful human challenge model for dengue serotype 4, a major advance that could speed the development of new drugs and vaccines against a…